|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Safiri S, Kolahi AA and Naghavi M; Global
Burden of Disease Bladder Cancer Collaborators, : Global, regional
and national burden of bladder cancer and its attributable risk
factors in 204 countries and territories, 1990–2019: A systematic
analysis for the global burden of disease study 2019. BMJ Glob
Health. 6:e0041282021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Kratzer TB, Giaquinto AN, Sung
H and Jemal A: Cancer statistics, 2025. CA Cancer J Clin. 75:10–45.
2025.PubMed/NCBI
|
|
4
|
Lynch CF and Cohen MB: Urinary system.
Cancer. 75 (1 Suppl):S316–S329. 1995. View Article : Google Scholar
|
|
5
|
Scosyrev E, Noyes K, Feng C and Messing E:
Sex and racial differences in bladder cancer presentation and
mortality in the US. Cancer. 115:68–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jubber I, Ong S, Bukavina L, Black PC,
Compérat E, Kamat AM, Kiemeney L, Lawrentschuk N, Lerner SP, Meeks
JJ, et al: Epidemiology of bladder cancer in 2023: A systematic
review of risk factors. Eur Urol. 84:176–190. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hecht SS: Cigarette smoking: Cancer risks,
carcinogens, and mechanisms. Langenbecks Arch Surg. 391:603–613.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Amin HAA, Kobaisi MH and Samir RM:
Schistosomiasis and bladder cancer in Egypt: Truths and Myths. Open
Access Maced J Med Sci. 7:4023–4029. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martin JW, Jefferson FA, Huang M, Sung JM,
Chang J, Piranviseh K, Ziogas A, Anton-Culver H and Youssef RF: A
california cancer registry analysis of urothelial and
non-urothelial bladder cancer subtypes: Epidemiology, treatment,
and survival. Clin Genitourin Cancer. 18:e330–e336. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lopez-Beltran A and Cheng L: Histologic
variants of urothelial carcinoma: Differential diagnosis and
clinical implications. Hum Pathol. 37:1371–1388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Bui MM and Xu B: Urothelial
carcinoma with squamous differentiation ıs associated with high
tumor stage and pelvic lymph-node metastasis. Cancer Control.
24:78–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gellert LL, Warrick J and Al-Ahmadie HA:
Urothelial carcinoma with squamous differentiation-the
pathologists' perspective. Urol Oncol. 33:437–443. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Billis A, Schenka AA, Ramos CC, Carneiro
LT and Araújo V: Squamous and/or glandular differentiation in
urothelial carcinoma: Prevalence and significance in transurethral
resections of the bladder. Int Urol Nephrol. 33:631–633. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Logothetis CJ, Johnson DE, Chong C, Dexeus
FH, Sella A, Ogden S, Smith T, Swanson DA, Babaian RJ, Wishnow KI,
et al: Adjuvant cyclophosphamide, doxorubicin, and cisplatin
chemotherapy for bladder cancer: An update. J Clin Oncol.
6:1590–1596. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Martin JE, Jenkins BJ, Zuk RJ, Blandy JP
and Baithun SI: Clinical importance of squamous metaplasia in
invasive transitional cell carcinoma of the bladder. J Clin Pathol.
42:250–253. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wasco MJ, Daignault S, Zhang Y, Kunju LP,
Kinnaman M, Braun T, Lee CT and Shah RB: Urothelial carcinoma with
divergent histologic differentiation (mixed histologic features)
predicts the presence of locally advanced bladder cancer when
detected at transurethral resection. Urology. 70:69–74. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mori K, Abufaraj M, Mostafaei H, Quhal F,
Karakiewicz PI, Briganti A, Kimura S, Egawa S and Shariat SF: A
systematic review and meta-analysis of variant histology in
urothelial carcinoma of the bladder treated with radical
cystectomy. J Urol. 204:1129–1140. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Minato A, Noguchi H, Tomisaki I, Fukuda A,
Kubo T, Nakayama T and Fujimoto N: Clinical significance of
squamous differentiation in urothelial carcinoma of the bladder.
Cancer Control. 25:10732748188002692018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Izard JP, Siemens DR, Mackillop WJ, Wei X,
Leveridge MJ, Berman DM, Peng Y and Booth CM: Outcomes of squamous
histology in bladder cancer: A population-based study. Urol Oncol.
33:425.e7–e13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Monn MF, Kaimakliotis HZ, Pedrosa JA, Cary
KC, Bihrle R, Cheng L and Koch MO: Contemporary bladder cancer:
Variant histology may be a significant driver of disease. Urol
Oncol. 33:18.e15–e18.e20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim SP, Frank I, Cheville JC, Thompson RH,
Weight CJ, Thapa P and Boorjian SA: The impact of squamous and
glandular differentiation on survival after radical cystectomy for
urothelial carcinoma. J Urol. 188:405–409. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mitra AP, Bartsch CC, Bartsch G Jr,
Miranda G, Skinner EC and Daneshmand S: Does presence of squamous
and glandular differentiation in urothelial carcinoma of the
bladder at cystectomy portend poor prognosis? An intensive
case-control analysis. Urol Oncol. 32:117–127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pereira JN, Reis JD, Braga I, Freitas R,
Moreira da Silva V, Magalhães S, Lobo F and Morais A: Variant
histologies of urothelial carcinoma: Does it change the survival
outcomes in patients managed with radical cystectomy? Arch Ital
Urol Androl. 94:138–143. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xylinas E, Rink M, Robinson BD, Lotan Y,
Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, et al:
Impact of histological variants on oncological outcomes of patients
with urothelial carcinoma of the bladder treated with radical
cystectomy. Eur J Cancer. 49:1889–1897. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Antunes AA, Nesrallah LJ, Dall'Oglio MF,
Maluf CE, Camara C, Leite KR and Srougi M: The role of squamous
differentiation in patients with transitional cell carcinoma of the
bladder treated with radical cystectomy. Int Braz J Urol.
33:339–346. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Q, Li L, Wang G, Hu J, Sun T and Fu
B: Do histological variants in urothelial carcinoma of the bladder
portend poor prognosis? A systematic review and meta-analysis.
Oncotarget. 8:48263–48271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
WHO Classification of Tumours Editorial
Board, . Urinary and male genital tumours. WHO classification of
tumours. 5th edition. volume 8. International Agency for Research
on Cancer; Lyon: 2022, https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Urinary-And-Male-Genital-Tumours-2022April
24–2026
|
|
28
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of urothelial bladder
carcinoma. Nature. 507:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choi W, Porten S, Kim S, Willis D, Plimack
ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, et al:
Identification of distinct basal and luminal subtypes of
muscle-invasive bladder cancer with different sensitivities to
frontline chemotherapy. Cancer Cell. 25:152–165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Agrawal P, Rostom M, Alam R, Florissi I,
Biles M, Rodriguez K, Hahn NM, Johnson BA III, Matoso A, Smith A,
et al: Clinicopathologic and survival after cystectomy outcomes in
squamous cell carcinoma of the bladder. Clin Genitourin Cancer.
21:631–638.e1. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gaisa NT, Braunschweig T, Reimer N,
Bornemann J, Eltze E, Siegert S, Toma M, Villa L, Hartmann A and
Knuechel R: Different immunohistochemical and ultrastructural
phenotypes of squamous differentiation in bladder cancer. Virchows
Arch. 458:301–312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moschini M, Sharma V, Dell'oglio P,
Cucchiara V, Gandaglia G, Cantiello F, Zattoni F, Pellucchi F,
Briganti A, Damiano R, et al: Comparing long-term outcomes of
primary and progressive carcinoma invading bladder muscle after
radical cystectomy. BJU Int. 117:604–610. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kayama E, Kikuchi E, Fukumoto K, Shirotake
S, Miyazaki Y, Hakozaki K, Kaneko G, Yoshimine S, Tanaka N,
Takahiro M, et al: History of non-muscle-ınvasive bladder cancer
may have a worse prognostic ımpact in cT2-4aN0M0 bladder cancer
patients treated with radical cystectomy. Clin Genitourin Cancer.
16:e969–e976. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vlaming M, Kiemeney LALM and van der
Heijden AG: Survival after radical cystectomy: Progressive versus
de novo muscle invasive bladder cancer. Cancer Treat Res Commun.
25:1002642020.PubMed/NCBI
|
|
35
|
Lin W, Pan X, Zhang C, Ye B and Song J:
Impact of age at diagnosis of bladder cancer on survival: A
surveillance, epidemiology, and end results-based study 2004–2015.
Cancer Control. 30:107327482311523222023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Laymon M, Mosbah A, Hashem A, Mahmoud O,
Harraz AM, Elsawy AA and Abol-Enein H: Oncologic outcomes of
squamous cell carcinoma versus urothelial carcinoma with squamous
differentiation after radical cystectomy for bladder carcinoma.
Clin Genitourin Cancer. 20:148–154. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Alfred Witjes J, Max Bruins H, Carrión A,
Cathomas R, Compérat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A,
Martini A, et al: European association of urology guidelines on
muscle-invasive and metastatic bladder cancer: Summary of the 2023
guidelines. Eur Urol. 85:17–31. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Freedman ND, Silverman DT, Hollenbeck AR,
Schatzkin A and Abnet CC: Association between smoking and risk of
bladder cancer among men and women. JAMA. 306:737–745. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mungan NA, Kiemeney LA, van Dijck JA, van
der Poel HG and Witjes JA: Gender differences in stage distribution
of bladder cancer. Urology. 55:368–371. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Marks P, Soave A, Shariat SF, Fajkovic H,
Fisch M and Rink M: Female with bladder cancer: What and why is
there a difference? Transl Androl Urol. 5:668–682. 2016. View Article : Google Scholar : PubMed/NCBI
|
